市場調査レポート

商品コード

1701003

ポイントオブケア診断市場規模、シェア、成長分析、製品別、購入形態別、技術別、サンプル別、エンドユーザー別、地域別-2025～2032年産業予測

Point Of Care Diagnostics Market Size, Share, and Growth Analysis, By Product, By Mode Of Purchase, By Technology, By Sample, By End User, By Region - Industry Forecast 2025-2032

出版日: 2025年04月04日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 780,584円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 913,136円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,045,688円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=147.28円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界のポイントオブケア診断市場規模は2023年に451億米ドルと評価され、予測期間（2025～2032年）のCAGRは9.3%で、2024年の492億9,000万米ドルから2032年には1,004億1,000万米ドルに成長する展望です。

ポイントオブケア（POC）診断市場は、POC機器の技術進歩、感染症の急増、主要企業の投資拡大などを背景に力強い成長を遂げています。結核やエイズなどの感染症が急増していることに加え、検査結果をすぐに知りたいという患者のニーズが市場拡大を後押ししています。この動向は、より患者中心の機器やソリューションを求める医療セクタの動きを浮き彫りにしています。マイクロフルイディクスとマイクロファブリケーションの革新により、POC診断はより安価で使いやすく、携帯可能で効率的なものとなり、患者ケアに革命をもたらしています。各社はマイクロ流体技術の強化を目指した研究にますますリソースを投入しており、患者の予後改善を約束し、開発をさらに後押ししています。全体として、POC診断の状況は大きく進化し続けており、医療プロバイダと患者のニーズを同様に満たしています。

市場概要
血糖値モニタリング製品
- 血糖モニタリングストリップ
- 血糖モニタリングメーター
- 血糖モニタリング用ランセットと穿刺器具
心臓代謝モニタリング製品
- 心臓マーカー検査製品
- 血液ガス/電解質検査製品
- HBA1C検査製品
感染症検査製品
- 呼吸器感染症検査製品
- 医療関連感染検査製品
- 熱帯病検査製品
- 性感染症検査製品
凝固モニタリング製品
- PT/INR検査製品
- ACT/APTT検査製品
妊娠・不妊検査製品
腫瘍/がんマーカー検査製品
尿検査製品
コレステロール検査製品
血液検査製品
薬剤乱用検査製品
甲状腺刺激ホルモン検査製品
便潜血検査製品
その他

ポイントオブケア診断市場規模：購入形態別&CAGR（2025～2032年）

市場概要
処方薬検査製品
市販薬検査製品

ポイントオブケア診断市場規模：技術別&CAGR（2025～2032年）

市場概要
生化学
免疫測定
分子診断
- RT-PCR
- INAAT

ポイントオブケア診断市場規模：サンプル別&CAGR（2025～2032年）

市場概要
血液サンプル
鼻腔と口腔咽頭スワブ
尿サンプル
その他のサンプル

ポイントオブケア診断市場規模：エンドユーザー別&CAGR（2025～2032年）

市場概要
在宅ケア環境と自己検査
臨床検査室
病院、救命救急センター、緊急治療センター
外来診療施設と医師のクリニック
その他

ポイントオブケア診断市場規模&CAGR（2025～2032年）

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他の欧州
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
ラテンアメリカ
- ブラジル
- その他のラテンアメリカ
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他の中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主要市場企業が採用した戦略
最近の市場動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022～2024年）
  主要企業プロファイル
  - Abbott Laboratories（米国）
  - Siemens Healthineers AG（ドイツ）
  - Quidel Corporation（米国）
  - F. Hoffman-La Roche Ltd.（スイス）
  - Danaher Corporation（米国）
  - Becton, Dickinson and Company（米国）
  - Chembio Diagnostics（米国）
  - EKF Diagnostics（英国）
  - Trinity BIoTech plc（アイルランド）
  - Instrumentation Laboratory（米国）
  - PTS Diagnostics（米国）
  - Sekisui Diagnostics（米国）

結論と提言

Product Code: SQMIG35I2098

Global Point Of Care Diagnostics Market size was valued at USD 45.1 billion in 2023 and is poised to grow from USD 49.29 billion in 2024 to USD 100.41 billion by 2032, growing at a CAGR of 9.3% during the forecast period (2025-2032).

The point of care (POC) diagnostics market is witnessing robust growth driven by technological advancements in POC devices, a surge in infectious diseases, and heightened investments from leading companies. The escalating prevalence of conditions such as tuberculosis and AIDS, alongside patients' demand for immediate test results, fuels market expansion. This trend underscores the healthcare sector's push for more patient-centric devices and solutions. With innovations in microfluidics and microfabrication, POC diagnostics have become more affordable, user-friendly, portable, and efficient, revolutionizing patient care. Companies are increasingly channeling resources into research aimed at enhancing microfluidic technology, promising improved outcomes for patients and further propelling market development. Overall, the POC diagnostics landscape continues to evolve significantly, meeting the needs of healthcare providers and patients alike.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Point Of Care Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Point Of Care Diagnostics Market Segments Analysis

Global Point Of Care Diagnostics Market is segmented by Product, Mode Of Purchase, Technology, Sample, End User and region. Based on Product, the market is segmented into Glucose Monitoring Products, Cardiometabolic Monitoring Products, Infectious Disease Testing Products, Coagulation Monitoring Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-Of-Abuse Testing Products, Thyroid-Stimulating Hormone Testing Products, Fecal Occult Testing Products and Other Products. Based on Mode Of Purchase, the market is segmented into Prescription-Based Testing Products and OTC Testing Products. Based on Technology, the market is segmented into Biochemistry, Immunoassays and Molecular Diagnostics. Based on Sample, the market is segmented into Blood Samples, Nasal & Oropharyngeal Swabs, Urine Samples and Other Samples. Based on End User, the market is segmented into Home Care Settings and Self-Testing, Clinical Laboratories, Hospitals, Critical Care Centers, and Urgent Care Centers, Ambulatory Care Facilities and Physician Offices and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Point Of Care Diagnostics Market

The Global Point of Care Diagnostics market is significantly propelled by ongoing technological advancements that aim to improve the usability of diagnostic devices. These innovations enhance the functionality and efficiency of point-of-care testing, allowing for quicker and more accurate results. As healthcare providers increasingly seek reliable and user-friendly solutions, the integration of cutting-edge technologies such as artificial intelligence, mobile connectivity, and portable testing equipment becomes crucial. This focus on enhancing usability not only facilitates better patient outcomes but also streamlines workflows in various clinical settings, driving the demand for advanced diagnostic tools in the global market.

Restraints in the Global Point Of Care Diagnostics Market

One of the significant restraints of the global point-of-care diagnostics market is the high initial investment costs associated with the development and implementation of diagnostic technologies. These expenses can pose a barrier for healthcare providers, particularly smaller facilities or those in developing regions, limiting their ability to adopt advanced diagnostic solutions. Additionally, the financial burden can deter investment in new technologies, hindering innovation and slowing the overall growth of the market. As a result, addressing these high upfront costs is crucial for enhancing the accessibility and widespread utilization of point-of-care diagnostic services worldwide.

Market Trends of the Global Point Of Care Diagnostics Market

The Global Point Of Care Diagnostics market is witnessing significant growth driven by advancements in personalized medicine. As healthcare shifts towards individualized treatment approaches, the demand for rapid, accurate diagnostics at the point of care is on the rise. Innovative technologies, such as portable devices and microfluidics, enable healthcare professionals to deliver real-time, tailored testing results that enhance patient outcomes. Moreover, integration with digital health platforms and data analytics is streamlining the diagnostic process, fostering greater accessibility and efficiency. As a result, stakeholders are increasingly investing in point-of-care solutions to meet the evolving needs of personalized healthcare, positioning the market for robust expansion.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Patent Analysis
Regulatory Analysis
Technology Analysis
Case Studies
Customer And Buying Criteria Analysis

Global Point Of Care Diagnostics Market Size by Product & CAGR (2025-2032)

Market Overview
Glucose Monitoring Products
- Glucose Monitoring Strips
- Glucose Monitoring Meters
- Glucose Monitoring Lancets & Lancing Devices
Cardiometabolic Monitoring Products
- Cardiac Marker Testing Products
- Blood Gas/Electrolyte Testing Products
- HBA1C Testing Products
Infectious Disease Testing Products
- Respiratory Infection Testing Products
- Healthcare-Associated Infection Testing Products
- Tropical Disease Testing Products
- Sexually Transmitted Disease Testing Products
Coagulation Monitoring Products
- PT/INR Testing Products
- ACT/APTT Testing Products
Pregnancy & Fertility Testing Products
Tumor/Cancer Marker Testing Products
Urinalysis Testing Products
Cholesterol Testing Products
Hematology Testing Products
Drugs-Of-Abuse Testing Products
Thyroid-Stimulating Hormone Testing Products
Fecal Occult Testing Products
Other Products

Global Point Of Care Diagnostics Market Size by Mode Of Purchase & CAGR (2025-2032)

Market Overview
Prescription-Based Testing Products
OTC Testing Products

Global Point Of Care Diagnostics Market Size by Technology & CAGR (2025-2032)

Market Overview
Biochemistry
Immunoassays
Molecular Diagnostics
- RT-PCR
- INAAT

Global Point Of Care Diagnostics Market Size by Sample & CAGR (2025-2032)

Market Overview
Blood Samples
Nasal & Oropharyngeal Swabs
Urine Samples
Other Samples

Global Point Of Care Diagnostics Market Size by End User & CAGR (2025-2032)

Market Overview
Home Care Settings and Self-Testing
Clinical Laboratories
Hospitals, Critical Care Centers, and Urgent Care Centers
Ambulatory Care Facilities and Physician Offices
Other End Users

Global Point Of Care Diagnostics Market Size & CAGR (2025-2032)

North America (Product, Mode Of Purchase, Technology, Sample, End User)
- US
- Canada
Europe (Product, Mode Of Purchase, Technology, Sample, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Mode Of Purchase, Technology, Sample, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Mode Of Purchase, Technology, Sample, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Mode Of Purchase, Technology, Sample, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quidel Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffman-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Chembio Diagnostics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EKF Diagnostics (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trinity Biotech plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Instrumentation Laboratory (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PTS Diagnostics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sekisui Diagnostics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments